BeOne Medicines Ltd's total assets for Q2 2026 were $9.18B, an increase of 7.23% from the previous quarter. MX:6160N total liabilities were $4.00B for the fiscal quarter, a 5.50% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.